[3只股价不到$15的 #生物科技 股] 一只股票价格低不仅不意味着便宜，反而是风险的体现。但以下3只生物科技股都是例外：

#Novavax Inc $NVAX
#MannKind Corp. $MNKD
#Anavex Life Sciences Corp $AVXL

了解更多：ow.ly/tLm050Mve7e

#investing #biotech #pharmaceuticals #lifescience

Here's what climbed to the top of the Delta Trending this week 🧗‍♂️

#HUT | Hut 8
#OPEN | Opendoor Tech
#AVXL | Anavex Life Sciences
#MSTR | MicroStrategy
#NIO | NIO
#COIN | Coinbase
#SPOT | Spotify
#IBM | International Business Machines
#TTWO | Take-Two Interactive
#NVDA | Nvidia

We've waited for soooooooo~~ long to see the great moment. We are almost there.
I am betting for MAA approval PR on the week of Jun 24, 2024.
This aligns with why ASM to be held by end of Jun, per 10-Q.

Anavex Life Sciences Corporation Class Action Lawsuit $AVXL

Anavex Deadline: May 7, 2024

Learn More Here: faruqilaw.com/AVXL

#faruqilaw #NASDAQ #NASDAQ Listed #stocks #stockmarketnews #StocksInNews #investing

Anavex Life Sciences to Present at the H.C. Wainwright 2nd BioConnect Investor Conference at NASDAQ

#anavex #biopharma #neuroscience #precisionmedicine

anavex.com/post/anavex-li…

Ugekommentar #122
Novo Nordisk, Gubra, Zealand Pharma, Bavarian, Genmab, Ultimovacs, Anavex, Teva
Kort video: proinvestor.com/boards/119556
#aktier

The accumulation of 'junk proteins' has been identified as one cause of aging.

SIGMAR1, which is activated by ANAVEX compounds, has been demonstrated to reduce accumulation of junk proteins.

#anavex #Biopharma #neuroscience #precisionmedicine

$AVXL reported topline results from its Phase 2/3 EXCELLENCE clinical trial of 30 mg ANAVEX 2-73 in 92 pediatric patients with Rett syndrome (RTT) between the ages of 5-17 years. The LS Mean difference (SE) of -4.61 (2.439) points between treated and placebo groups did not reach

Anavex Life Sciences Shares Rise 10% on Submitted Application to EMA for Blarcamesine
$AVXL
#AInvest #Ainvest_Wire #investor #trade #tradingtips
View more: ftn.ai/T5PH0FCA5

Anavex Life Sciences receives U.S. patent for Blarcamesine (ANAVEX®2-73) to treat neurodevelopmental disorders.

More Info: pryzm.ozmosi.com/product/14476 $XBI $IBB $XPH $PPH

Anavex Life Sciences Initiates Placebo-Controlled U.S. Phase 2 Clinical Trial of ANAVEX®3-71 in Schizophrenia

#anavex #biopharma #neuroscience #precisionmedicine

anavex.com/post/anavex-li…

$AVXL #fail
Anavex Life Sciences Provides an Update on Rett Syndrome Program - AVXL • BioPharmCatalyst biopharmcatalyst.com/company/AVXL/n…

Anavex Life Sciences to Announce Fiscal 2024 Second Quarter Financial Results on Thursday, May 9th, 2024

Webcast and Conference Call To be Held Thursday, May 9th, 2024, 8:30 am ET

anavex.com/post/anavex-li…

#anavex #biopharma #neuroscience #precisionmedicine

Anavex Life Sciences to Present at the Noble Capital Markets Virtual Healthcare Equity Conference

anavex.com/post/anavex-li…

#Anavex #Biopharma #neuroscience #precisionmedicine

Anavex Life Sciences to Present at the 23rd Annual Needham Virtual Healthcare Conference
#anavex #biopharma #neuroscience #precisionmedicine

anavex.com/post/anavex-li…

AVXL STOCKHOLDERS: Contact Robbins LLP for Information About Your Rights and Remedies Against Anavex Life Sciences Corporation dlvr.it/T4sFr1

Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Anavex Life Sciences Corp. (AVXL) dlvr.it/T4hrRN

The Law Offices of Frank R. Cruz Announces the Filing of a Securities Class Action on Behalf of Anavex Life Sciences Corp. (AVXL) Investors dlvr.it/T4bY7Z

Deadline Reminder: Law Offices of Howard G. Smith Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Anavex Life Sciences Corp. (AVXL) dlvr.it/T4f1vv

INVESTOR ALERT: Law Offices of Howard G. Smith Announces the Filing of a Securities Class Action on Behalf of Anavex Life Sciences Corp. (AVXL) Investors dlvr.it/T4Q4Xl